tirzepatide gip/glp-1 dual action drops is a first-in-class agonist targeting both GIP and gip/glp 1-agonist tirzepatide GLP1-GIP receptor

Mounjaro tends to be more effective for weight loss

doi:10.1017/S0033291716002932 Adeoye O, Olawumi J, Opeyemi A, Christiania O

Using expired medication can lead to reduced results or potential safety risks

When you introduce a compound that causes such a dramatic systemic shift, you have to anticipate the possibility of downstream effects that weren't immediately obvious

I see a massive increase or uptick in food sensitivities

Clinical trials involving approximately 900 participants found that the peptides adverse event profile was indistinguishable from placebo for most parameters, with no serious adverse events attributed to treatment